Table 1.
Demographics and clinical characteristics of the study sample at baseline assessment.
| Measure | Non-misusers (N=43) | Misusers (N=57) | Statistical test |
|---|---|---|---|
| Gender (M/F) | χ2=2.13 | ||
| Female N (%) | 27 (62.8) | 34 (60.7) | |
| Age (M ± SD) | 57.0 ± 12.1 | 51.3 ± 11.8 | t=2.37* |
| Race/Ethnicity | χ2=2.15 | ||
| Caucasian N (%) | 40 (93.0) | 53 (94.6) | |
| African American N (%) | - | 1 (1.8) | |
| Latino N (%) | 1 (2.3) | 1 (1.8) | |
| Asian/Pacific Islander N (%) | 1 (2.3) | - | |
| Other | 1 (2.3) | 1 (1.8) | |
| Primary pain condition | χ2=4.41 | ||
| Lower back N (%) | 22 (51.2) | 30 (53.6) | |
| Joint/arthritis N (%) | 5 (11.6) | 10 (17.9) | |
| Head/neck N (%) | 2 (4.7) | 6 (10.7) | |
| Fibromyalgia N (%) | 5 (11.6) | 5 (8.9) | |
| Other | 9 (20.9) | 5 (8.9) | |
| Clinical characteristics (M ± SD) | |||
| COMM | 9.2 ± 3.1 | 21.1 ± 7.1 | t=10.29* |
| Opioid use disorder symptoms | 2.2 ± 2.3 | 4.1 ± 2.9 | t=3.50* |
| Morphine equivalent units per day | 79.4 ± 103.1 | 89.9 ± 136.8 | t=0.42 |
| BPI, Pain Severity | 5.0 ± 1.4 | 5.2 ± 1.4 | t=0.47 |
| BPI, Pain Interference | 5.8 ± 1.8 | 6.3 ± 1.9 | t=1.44 |
Note. Characterization of opioid non-misusers and misusers was based on the Current Opioid Misuse Measure (COMM), where the threshold for misuser was a score of ≥13.